載入...

Cholesterol Ester Transfer Protein Inhibitor Review

Treatment of blood cholesterol is part of a strategy to lower atherosclerotic cardiovascular (ASCVD) risk. While use of HMG-CoA reductase inhibitors to modify cholesterol levels is the primary means of lowering the risk of an ASCVD event, residual risk remains. A new strategy being investigated is t...

全面介紹

Na minha lista:
書目詳細資料
發表在:Hosp Pharm
Main Authors: Hu, Jerry, Walker, Scot
格式: Artigo
語言:Inglês
出版: SAGE Publications 2017
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5735735/
https://ncbi.nlm.nih.gov/pubmed/29276295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578717729669
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!